{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:09:11Z","timestamp":1792015751272,"version":"4.4.0"},"reference-count":30,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2007,12,10]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p> Dose escalation has been shown to improve local control in non\u2013small-cell lung cancer (NSCLC) treated with definitive radiation therapy, but with increased complications. We implemented the use of involved-field radiotherapy (IFRT) in an effort to reduce toxicity while treating the gross tumor to higher doses. This analysis reports failure rates in uninvolved nodal regions with the use of IFRT. <\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p> A total of 524 patients with NSCLC treated with three-dimensional conformal radiotherapy at Memorial Sloan-Kettering Cancer Center between 1991 and 2005 were reviewed. Only lymph node regions initially involved with tumor by either biopsy or radiographic criteria were included in the clinical target volume. Elective nodal failure (ENF) was defined as a recurrence in an initially uninvolved lymph node in the absence of local failure. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> Only 32 patients (6.1%) with ENF were identified. The 2-year actuarial rates of elective nodal control and primary tumor control were 92.4% and 51%, respectively, with a median follow-up of 41 months in survivors. In patients who achieved local disease control, the 2-year elective nodal control rate was 91%. The median time to ENF was 6 months (range, 0 to 56 months). Many patients experienced treatment failure in multiple lymph node regions simultaneously. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> The use of IFRT did not cause a significant amount of failure in lymph node regions not included in the tumor volume. Therefore, IFRT remains an acceptable method of treatment that allows for dose escalation while minimizing toxicity. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.2007.13.2191","type":"journal-article","created":{"date-parts":[[2007,11,6]],"date-time":"2007-11-06T01:34:12Z","timestamp":1194312852000},"page":"5557-5561","source":"Crossref","is-referenced-by-count":149,"title":["Involved-Field Radiation Therapy for Inoperable Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1200","volume":"25","author":[{"given":"Kenneth E.","family":"Rosenzweig","sequence":"first","affiliation":[{"name":"From the Departments of Radiation Oncology and Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Sura","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Oncology and Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jackson","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Oncology and Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Yorke","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Oncology and Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.011"},{"key":"R2","unstructured":"Emami B, Graham MV: Lung, in Perez C, Brady LW (eds): Principles and Practice of Radiation Oncology . New York, NY, Lippincott-Raven, pp 1181,1998-1220"},{"key":"R3","unstructured":"Marks LB, Prosnitz LR: Assessing the impact of elective regional radiotherapy on survival. Cancer J Sci Am 5:92,1999-100,"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Pu AT, Harrison JM, Robertson JA, et al: The toxicity of elective nodal irradiation in the definitive treatment of non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 39:196,1997,  (abstr 2)","DOI":"10.1016\/S0360-3016(97)80680-3"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21007"},{"key":"R6","unstructured":"Rosenzweig KE, Mychalzhak B, Fuks Z, et al: Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. Cancer J 6:82,2000-87,"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(01)01482-1"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)90033-5"},{"key":"R9","unstructured":"Mohan R: Dose computations for three-dimensional radiation treatment planning. Australas Phys Eng Sci Med 12:241,1989-251,"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Lyman JT: Complication probability as assessed from dose-volume histograms. Radiat Res Suppl S13,1985-S19,","DOI":"10.2307\/3583506"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Kutcher Gj, Burman C, Brewster L, et al: Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 21:137,1991-146,","DOI":"10.1016\/0360-3016(91)90173-2"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90172-Z"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(88)90098-3"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)02929-2"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2007.01.006"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(03)00228-9"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00098-9"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(99)00032-8"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.1.127"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)03028-6"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Sulman EP, Chang JY, Liao Z, et al: Exclusion of elective nodal irradiation does not decrease local regional control of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 63:S226,2005-S227,  (abstr 1)","DOI":"10.1016\/j.ijrobp.2005.07.387"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(99)00087-2"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)00667-2"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)04614-X"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Yuan S Sr, Yu J, Sun X Sr, et al: Three-dimensional conformal involved-field radiotherapy for stage III non-small cell lung cancer. J Clin Oncol 24:375s,2006,  (suppl; abstr 7044)","DOI":"10.1200\/jco.2006.24.18_suppl.7044"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(99)90204-3"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2003.11.009"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Pu AT, Harrison AS, Robertson JM, et al: The toxicity of elective nodal irradiation in the definitive treatment of non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 39:196,1997,  (abstr)","DOI":"10.1016\/S0360-3016(97)80680-3"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2007.13.2191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T20:11:57Z","timestamp":1653509517000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2007.13.2191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,10]]},"references-count":30,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2007,12,10]]}},"alternative-id":["10.1200\/JCO.2007.13.2191"],"URL":"https:\/\/doi.org\/10.1200\/jco.2007.13.2191","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,10]]}}}